Anti-CSNK2A1 antibody [EP1963Y]
- KO Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(15 Publications)
Rabbit Recombinant Monoclonal CSNK2A1 antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Mouse, Rat, Human samples. Cited in 15 publications.
View Alternative Names
CK2A1, CSNK2A1, Casein kinase II subunit alpha, CK II alpha
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
Intracellular Flow Cytometry analysis of Jurkat (Human T cell leukemia T lymphocyte) cells labeling CSNK2A1 with purified ab76040 at 1 : 20 dilution (10 μg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as a isotype control. Cell without incubation with primary antibody and secondary antibody (Blue) were used as unlabeled control.
- WB
Lab
Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
Lanes 1 - 4 : Merged signal (red and green). Green – ab76040 observed at 45 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab76040 was shown to specifically react with CSNK2A1 when CCSNK2A1 knockout samples were used. Wild-type and CSNK2A1 knockout samples were subjected to SDS-PAGE. ab76040 and ab8245 (loading control to GAPDH) were diluted at 1/500 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CSNK2A1 antibody [EP1963Y] (ab76040) at 1/500 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
CSNK2A1 knockout HAP1 cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Predicted band size: 45 kDa
false
- WB
Lab
Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
Lanes 1-2 : Merged signal (red and green). Green - ab76040 observed at 45 kDa. Red - loading control ab8245 observed at 37 kDa.
ab76040 Anti-CSNK2A1 antibody [EP1963Y] was shown to specifically react with CSNK2A1 in wild-type HCT116 cells. Loss of signal was observed when knockout cell line ab266864 (knockout cell lysate ab257401) was used. Wild-type and CSNK2A1 knockout samples were subjected to SDS-PAGE. ab76040 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CSNK2A1 antibody [EP1963Y] (ab76040) at 1/1000 dilution
Lane 1:
Wild-type HCT116 cell lysate at 20 µg
Lane 2:
CSNK2A1 knockout HCT116 cell lysate at 20 µg
Lane 2:
Western blot - Human CSNK2A1 knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-csnk2a1-knockout-hct116-cell-line-ab266864'>ab266864</a>)
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
- WB
Unknown
Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
All lanes:
Western blot - Anti-CSNK2A1 antibody [EP1963Y] (ab76040) at 1/1000 dilution
All lanes:
HeLa cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
- WB
Lab
Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CSNK2A1 antibody [EP1963Y] (ab76040) at 1/1000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 15 µg
Lane 2:
Mouse brain lysate at 15 µg
Lane 3:
Rat brian lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
- WB
Lab
Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
ab76040 was shown to react with CSNK2A1 in wild-type HAP1 cells in Western blot with loss of signal observed in a CSNK2A1 knockout cell line. Wild-type HAP1 and CSNK2A1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab76040 overnight at 4 °C at a 1/500 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-CSNK2A1 antibody [EP1963Y] (ab76040) at 1/500 dilution
Lane 1:
Wild-type HAP1 lysate at 30 µg
Lane 2:
CSNK2A1 knock-out HAP1 lysate at 30 µg
false
Related conjugates and formulations (8)
-
660 APC
APC Anti-CKII alpha antibody [EP1963Y]
-
HRP Anti-CKII alpha antibody [EP1963Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CKII alpha antibody [EP1963Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CKII alpha antibody [EP1963Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CKII alpha antibody [EP1963Y]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-CSNK2A1 antibody [EP1963Y]
-
578 PE
PE Anti-CKII alpha antibody [EP1963Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CKII alpha antibody [EP1963Y]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular medicine 56: PubMed40927979
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical, cosmetic and investigational dermatology 18:1971-1983 PubMed40860313
2025
Applications
Unspecified application
Species
Unspecified reactive species
F1000Research 13:781 PubMed39403680
2024
Applications
WB, ICC
Species
Human, Human
Nature cardiovascular research 2:835-852 PubMed38075556
2023
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 42:e114051 PubMed38059508
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 209:896-906 PubMed35914835
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 16:911973 PubMed35928572
2022
Applications
Unspecified application
Species
Unspecified reactive species
PeerJ 9:e12519 PubMed34993017
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:4671 PubMed34344863
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 11:10135-10143 PubMed31819646
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com